Reading Fortune this afternoon, tiny little plug
for BSX on p. 40 in Touring the Future of
Haseltine described recent clinical trials involving
angiogenesis genes--which tell the boyd how to grow new blood
vessels--that have been injected into the leges of "people
walking around today who otherwise would be amputees."
(At this, Boston Scientific co-chairman John Abele
leaned over in his seat to tell Fortune that his
company's tiny catheters were involved in some of these
I am not in the medical field. I would like to
learn more about BSX and what it does besides stents.
And information that is available about what they are
working on. Anyone have input??
Those looking for the next medical device winner
might want to check out POSS. These are the folks who
invented the heart valve for St. Jude. Now they have an
amazing line of new devices in the pipeline.
you like, refer to message number 623 on the POSS
board, where i run through the numbers.
I know this product. I know
stents. I've seen what they are doing in Rotterdam. I
Know the members of the registry set up this month in
Look at the R Stent. Buy SPNC.
I made a lot
with AVEI and BSX. SPNC is next.
take my word for it. Do your own work...You'll see.
This isn't a problem, it's a market. Look at
Spectranetics (SPNC) and their solution using laser technology
And, by the way, their R Stent
(SPNC product now in Europe) will be the next
generation Stent anyway, so Doc's will be seeing their
solutions in the cath Lab along with the new
Ask Marty Leon,... he'll tell you.
Don't get too wrapped up in restenosis data, the
reality is that stents are here to stay, at least pending
different technolgy. Every one on these boards uses a
computer. You know the rules about computers...crap in-crap
out. Medical trials are the same thing. If the study
is designed to highlight the benefits of one product
vs. another - guess what happens. Remember the basics
of buying - you buy on emotion and back it with
logic. MD's are still people and have the same drives
and emotions as do plumbers, builders, etc. Look at
the historical growth of stents and you realize that
restenosis is the logic that allows the zealousness of the
I'm not disagreeing with you on that...I don't
know of any current documentation to support what I'm
saying....I'm just telling you what is happening out here in
the real world....cardiologists seem to be all caught
up in placement (short term benefits) instead of
long term patient outcomes....hmmm...hard to
believe...well its true!